Interrogation of the TCGA melanoma cohort (cBioPortal) supported the conclusions from our study, showing no correlation of CD24 expression with BRAF, NRAS, or ERK1 mutation or expression (though only 2% of cases are ERK1 mutant). The gene discussed is MAPK3; the disease is melanoma.